Lord, Abbett & Co. LLC Johnson & Johnson Transaction History

Lord, Abbett & Co. LLC

$28.1 Billion
Q1 2025

A detailed history of Lord, Abbett & Co. LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 706,099 shares of JNJ stock, worth $108 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

706,099

Previous 431,194 63.75%

Holding current value

$108 Million

Previous $62.4 Million 87.78%

% of portfolio

0.42%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$142.06 - $167.7 $39.1 Million - $46.1 Million	274,905 Added 63.75%	706,099 $117 Million
Q4 2024 Feb 14, 2025	BUY	$143.34 - $165.86 $18,347 - $21,230	128 Added 0.03%	431,194 $62.4 Million
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $62.7 Million - $72.2 Million	431,066 New	431,066 $69.9 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $16.8 Million - $18 Million	-105,242 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $107 Million - $119 Million	-699,156 Reduced 86.92%	105,242 $17.3 Million
Q4 2020 Feb 09, 2021	SELL	$137.11 - $157.38 $47.2 Million - $54.1 Million	-343,886 Reduced 29.95%	804,398 $127 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $42.4 Million - $46.4 Million	-301,697 Reduced 20.81%	1,148,284 $171 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $31.2 Million - $37.6 Million	241,850 Added 20.02%	1,449,981 $204 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $2.58 Million - $3.58 Million	23,219 Added 1.96%	1,208,131 $158 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $3.5 Million - $4.02 Million	-27,419 Reduced 2.26%	1,184,912 $173 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $36.5 Million - $40.9 Million	-287,702 Reduced 19.18%	1,212,331 $157 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $88.1 Million - $96.9 Million	-671,540 Reduced 30.92%	1,500,033 $209 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $15.2 Million - $16.9 Million	121,137 Added 5.91%	2,171,573 $304 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $20 Million - $24.1 Million	-163,147 Reduced 7.37%	2,050,436 $265 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $18.2 Million - $21.4 Million	149,748 Added 7.26%	2,213,583 $306 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $55.5 Million - $61.2 Million	-464,515 Reduced 18.37%	2,063,835 $250 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $30.8 Million - $36.5 Million	246,437 Added 10.8%	2,528,350 $324 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $5.13 Million - $5.62 Million	39,110 Added 1.74%	2,281,913 $319 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $32.8 Million - $34.3 Million	-253,597 Reduced 10.16%	2,242,803 $292 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,496,400	2,496,400 $330 Million

Others Institutions Holding JNJ

# of Institutions

4,652

Shares Held

1.73B

Call Options Held

25M

Put Options Held

15.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Johnson & Johnson Transaction History